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Prevention of Environmental
Pollution: Good for Our Health
Today, there is increasing recognition ofthe health costs, as well as
the ecological and economic costs, ofenvironmental contamination
and the need to avert damage through pollution prevention. The
shift from the strategy ofcontrolling pollutants after they have been
produced ("mopping up") to preventing their generation ("turning
off the faucet") is already beginning. However, the transition will
necessitate an integration of the two approaches and a continued
reliance on established methods to estimate risks and set priorities.
Indeed, scientists, environmentalists, and policy-makers are already
working together to strengthen and reorient the current environ-
mental program by incorporating new developments in toxicology
and management without discarding methodologies that remain
valid after decades of use.
At this point in the evolution ofnational environmental policy,
it is important that we take stock ofthe achievements, as well as the
failures, since the major environmental statutes were passed in the
1970s. Unfortunately, we often hear about the failures and not the
gains, and some critics have been harsh indeed, pronouncing past
and current environmental policy "the product ofbad science and
worse economics." They have dismissed as irrelevant laboratory
testing systems used for decades to screen chemicals for toxicity,
and they have discounted the health benefits ofenvironmental pro-
tection. The "bottom line" in theirview is that we have wasted vast
amounts of money to fix trivial risks and that sweeping reform is
needed. Although it represents an extreme position, this viewpoint
is particularly damaging at a time when public understanding is
essential to forward-looking initiatives such as efforts by EPA and
other federal agencies to reduce the use ofpesticides in this country.
What is the record on the health hazards ofenvironmental pol-
lutants? According to EPA, more than three and a half billion
pounds oftoxic chemicals are released each year directly to the air,
surface water, land, or to underground injection wells. An addition-
al one to two billion pounds ofpesticides are used each year in the
United States. A number ofyears ago a committee ofthe National
Research Council estimated that few of the 50,000 chemicals in
commerce and only 10% of pesticides and their inert ingredients
had sufficient information on toxicity for a complete health-hazard
evaluation. Even today we do not know enough about the potential
of most ofthe chemicals in our environment to cause such serious
effects as cancer, reproductive impairment, birth defects, harm to
the developing child, neurologic disease, and damage to the
immune system.
We do know, however, that most toxic chemicals exert multiple
effects, and some, like the chlorinated hydrocarbons, are highly per-
sistent in the environment and in body tissues, as illustrated by a
recent study linking elevated serum levels of the major DDT
metabolite with breast cancer (1). We have accumulated experi-
mental and human data showing that more than 390 chemicals are
cancer causing (2), 150 are reproductive and developmental toxi-
cants (2), and several hundred are neurotoxic (3). Although limited
in scope, our national monitoring network routinely detects hun-
dreds oftoxic chemicals in the air, drinking water, and food supply.
Some naturally occurring substances, such as the regulated dietary
contaminant aflatoxin, may also pose significant health hazards.
However, comparisons between the risks ofnatural carcinogens in
the diet versus the risks ofsynthetic pesticides are seriously limited
by the inadequacy ofdata on the identity, concentrations and car-
cinogenic potency ofboth types ofchemicals in the food supply.
Many researchers have shown that people vary widely in their
susceptibility to toxicants. For example, we have recently reported a
70-fold variation in the levels ofgenetic damage in people similarly
exposed to air pollution in an industrialized region of Eastern
Europe (4). This finding is consistent with results from parallel
studies ofworkers and cigarette smokers. Recognizing the impor-
tance ofinterindividual variability in susceptibility, a committee of
the National Academy of Sciences recommended changes in the
regulatory practices for pesticides in order to protect the health of
children (5).
In some cases, pollution has resulted in disease epidemics which
can't be missed: for example, it is estimated that asbestos exposure
will cause several hundred thousand deaths in American workers by
the year 2000 and that thousands of cases of neurologic disease
have resulted from exposure to organic mercury, tri-orthocresyl
phosphate, and Kepone. Recent studies indicate that as many as
60,000 deaths may occur each year in the United States as a result
of fine particulate air pollution. There is growing evidence that
environmental agents play a significant role in breast cancer causa-
tion (6). However, absent a rare "signal" effect, it has been extraor-
dinarily difficult to establish a direct link between a particular envi-
ronmental exposure and cases of chronic disease, especially those
with long latencies such as cancer. Epidemiologic studies ofhuman
populations are of limited usefulness in prevention because they
give answers only "after the fact" ofillness or death.
Therefore, a decision was made decades ago by the nation's
public health experts to screen chemicals using short-term and
whole-animal test systems as a surrogate for humans. Under the
established policy, the test results are then combined with all other
relevant data as a basis for regulatory decisions in the absence of
human data. Risks that are determined to be significant are then
subject to regulation.
Are current toxicologic testing methods fatally flawed as some
ofthe critics would have us believe? Unquestionably, the methodol-
ogy that has drawn the most criticism has been the use ofthe ani-
mal bioassay to screen for potential human carcinogens.
Epidemiologic studies have so far identified 50 human carcinogens,
all ofwhich, when properly tested, have been positive in animal
bioassays. The majority were first identified in humans; even in the
few cases where earlier animal tests had been positive, regulations
were generally imposed only after the human cases appeared.
Mindful ofthis experience, in the late 1970s Congress and regula-
tors put in place the National Toxicology Program to indude stud-
ies in which rodents are treated with test chemicals at and below
the maximum tolerated dose in order to be able to detect effects
within the animals' two- to three-yearlifetimes.
This practice has drawn increasing fire from critics because of
the possibility that the rodent tumors might result from high dose
toxicity alone and could mislead about potential low-level effects in
humans. While this is a serious concern and merits consideration,
the record is reassuring in that a recent analysis ofresults from the
National Toxicology Program indicates that the majority of car-
cinogens evaluated induce tumors at concentrations below the max-
imum dose given and that toxicity and carcinogenicity are not con-
sistently correlated (7). A National Research Committee majority
report recendy reaffirmed the validity ofthis approach for identify-
ing potential risks to humans (8). This does not mean that new,
more informative, faster, or less costly testing procedures should
not be developed. Indeed, important research is going on now at
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the National Institute of Environmental Health Sciences, acade-
mia, and elsewhere to develop and fine-tune testing and assessment
procedures that incorporate recent advances in molecular biology.
But there is broad agreement in the scientific and public health
community that thorough toxicologic testing is central to disease
prevention.
What successes can we claim? There have been important gains.
We have prevented and are continuing to prevent millions ofcases
of environmental disease including lung cancer and mesothelioma
from asbestos, damage to the developing nervous system of chil-
dren from lead, liver cancer from vinyl chloride, and male sterility
from dibromochloropropane, to name a few. For example, it is
estimated that during the 7 years after the 1985 regulation oflead
in gasoline, an estimated 10 million children were protected from
the neurodevelopmental effects oflead. The vast majority ofregu-
lations have considered the costs ofcontrol as well as technological
feasibility.
True, regulation is always undertaken in the face of consider-
able uncertainty concerning the health risks and the costs ofregula-
tion. Despite their apparent precision, quantitative estimates ofthe
numbers ofillnesses and deaths caused by toxic substances and the
monetary estimates of costs and benefits of regulations are really
only "guestimates" derived using assumptions where data are miss-
ing. Even a herculean research effort will not resolve all of the
unanswered questions. Recognizing this, President Clinton recent-
ly pledged to restrict emissions of greenhouse gases to reduce the
serious threat ofglobal warming. The same paradigm should apply
to the risks oftoxic substances.
The irony is that although environmentally related diseases are
bydefinition preventable, they continue to impose major economic
and human costs on society. They contribute to the spiralling
costs ofhealth care, which are expected to reach $940 billion this
year. For example, the health care costs ofcancer now exceed $100
billion dollars annually, or more than one-tenth of the nation's
health care bill (9). The majority of cancer is believed to be pre-
ventable: a result ofenvironmental factors such as cigarette smoke,
industrial pollutants, radiation, and diet. Even the most conserva-
tive estimates attribute 5-10% ofcancer to pollutants in the work-
place and ambient pollution, corresponding to 50,000-100,000
new cases ofcancer each year in the United States, with their atten-
dant health care costs. Taken together with the experience ofthe
last three decades, these considerations support a strengthened and
more cost-effective environmental policy centered on prevention.
Frederica Perera
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